Peter McNamara, Chief Scientific Officer at Tectonic Therapeutic, Inc. (TECX), sold 980 shares at $23.04 ($23K) on 2026-09-30, disclosed to the SEC on 2026-10-02.
Scheduled sale ($23k) by Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $23.67 | 444 | $11K | 46.0% |
| 2 | $23.04 | 536 | $12K | 54.0% |
| Total | $23.33 avg | 980 | $23K | 100% |
| Filing → |
| TECX | SELL | 2026-07-01 | $6K | — | Filing → |
| TECX | SELL | 2026-03-09 | $189K | — | Filing → |
| TECX | SELL | 2026-03-05 | $78K | — | Filing → |